Sartorius announces offer to acquire TAP
Sartorius Stedim Biotech made a cash offer to acquire the UK company TAP Biosystems Group plc (TAP Biosystems) through its wholly owned subsidiary Sartorius Stedim Biotech GmbH. The proposed transaction, which is subject to customary closing conditions, including the approval of TAP’s shareholders, values the equity of TAP Biosystems at approximately €33 million. The transaction has been unanimously approved by the boards of directors of both companies and is expected to close at the end of 2013.
Other news from the department business & finance
![Newsletter](https://img.chemie.de/assets/ceurope/images/newsletter.png)
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Distribution_(pharmacology)
![Basell Holdings B.V. - Hoofddorp, Netherlands](http://static.chemie.de//portal_assets/common/images/missing-logo-en.png)